Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

|Articles|May 9, 2019

Managing Your Site Selection at the Portfolio Level

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Related Content

Pharmaceutical Executive

Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX

ByNicholas Jacobus

November 7th 2025

Image Credit: Adobe Stock Images/Tada Images. The latest selections for the CNPV include therapies for obesity, cancer, sickle cell disease, and drug-resistant tuberculosis.

FDA Continues to Expand National Priority Voucher Program

November 7th 2025

Stock.adobe.com

FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma

ByNicholas Jacobus

November 7th 2025

Image Credit: Adobe Stock Images/Rawf8

Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?

ByThani Jambulingam, PhD

November 7th 2025

Deb Nevins is the Chief Marketing & Strategy Officer at POCN Group. POCN Group, an IQVIA business, is the life-sciences engagement division of POCN.

In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore

November 7th 2025

Trending on PharmExec

FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma

Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX

FDA Continues to Expand National Priority Voucher Program

In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore

Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?

© 2025 MJH Life Sciences^®

All rights reserved.